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Abstract
The diterpene forskolin (FS) binds to, and activates, mammalian membranous adenylyl cyclase (AC)
isoforms I–VIII. Diterpenes without C1-OH group do not activate ACs. The C1-OH group forms a
hydrogen bond with the backbone oxygen of Val506 of the C1 catalytic subunit of AC (isoform V
numbering). To better understand the mechanism of AC activation we examined the interactions of
FS and eight FS analogs with purified catalytic AC subunits C1 (AC V) and C2 (AC II) by
fluorescence spectroscopy, using 2′,3′-O-(N-methylanthraniloyl)-guanosine 5′-triphosphate
(MANT-GTP) as fluorescent reporter probe, and by enzymatic activity. FS analogs induced C1/C2
assembly as assessed by fluorescence resonance energy transfer from Trp1020 of C2 to MANT-GTP
and by increased direct MANT-GTP fluorescence in the order of efficacy FS ~ 7-deacetyl-FS ~ 6-
acetyl-7-deacetyl-FS ~ 9-deoxy-FS > 7-deacetyl-7-(N-methylpiperazino-γ-butyryloxy)-FS > 1-
deoxy-FS ~ 1,9-dideoxy-FS ~ 7-deacetyl-1-deoxy-FS ~ 7-deacetyl-1,9-dideoxy-FS. In contrast, FS
analogs activated catalysis in the order of efficacy FS > 7-deacety-FS ~ 6-acetyl-7-deacetyl-FS ~ 9-
deoxy-FS > 7-deacetyl-7-(N-methylpiperazino-γ-butyryloxy)-FS ≫ 1-deoxy-FS, 1,9-dideoxy-FS,
7-deacetyl-1-deoxy-FS and 7-deacetyl-1,9-dideoxy-FS (all ineffective). 1-Deoxy-FS analogs
inhibited FS-stimulated catalysis by an apparently non-competitive mechanism. Our data suggest a
two-step mechanism of AC activation by diterpenes. In the first step, diterpenes, regardless of their
substitution pattern, promote C1/C2 assembly. In the second and yet poorly understood step,
diterpenes that form a hydrogen bond between C1-OH and Val506 promote a conformational switch
that results in activation of catalysis. The apparent non-competitive interaction of FS with 1-deoxy-
FS analogs is explained by impaired ligand exchange due to strong hydrophobic interactions with
C1/C2.
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In mammals, nine membranous adenylyl cyclase (AC) isoforms are expressed [1–3]. ACs
catalyze the conversion of ATP into the second messenger cAMP and play a central role in
transmembrane signal transduction mediated by hormones and neurotransmitters. All AC
isoforms are activated by the G-protein Gs, and AC isoforms I–VIII (but not AC IX) are also
activated by the diterpene, forskolin (FS), which is produced in the roots of the Indian plant,
Coleus forskohlii. Fig. 1 shows the structures of FS and various FS analogs. The FS analogs
shown differ from each other in the OH-substitution of C1 and C9 and substitution at C6 or
C7 [4–6]. FS is of interest for the treatment of various disorders including cardiovascular
diseases, bronchial asthma, obesity and glaucoma [7]. As an important step towards the
achievement of this ambitious goal, there has been recent progress in the development of
isoform-specific FS analogs [8,9]. However, the precise mechanism by which FS activates AC
is still unknown.
A major advance to study AC at a molecular level was the establishment of a soluble
reconstituted system consisting of the C1 subunit of AC V and the C2 subunit of AC II. This
system is effectively activated by Gs and FS [10,11]. Crystal structures of C1/C2 bound to
various nucleotides including fluorescent 2′,3′-O-(N-methylanthraniloyl) (MANT)-substituted
nucleotides have been resolved [12–14]. MANT-nucleotides are used as reporter probes to
monitor conformational changes in C1/C2. Upon binding of FS to C1/C2, there is an increased
fluorescence resonance energy transfer (FRET) from Trp1020 of C2 to the MANT-group of
MANT-GTP and an increase in direct fluorescence [13,14]. Those data indicate that FS
promotes C1/C2 assembly, forming a hydrophobic pocket at the interface of the two subunits
to which the MANT-group binds and gives rise to the fluorescence signals.
Crystallographic studies showed that FS and its water-soluble analog DMB-FS [15] (Fig. 1I)
bind at the interface between C1 and C2, opposite to the catalytic site. FS interacts with C1/
C2 mostly via hydrophobic interactions [12–14] (Fig. 2A). In addition, there are hydrogen
bonds between the C1-OH group of FS and the backbone oxygen of Val506 of C1 (AC V
numbering), the C7-acetyl group of FS and Ser942 (AC II numbering) via a water molecule
and the C11-OH group of FS and Ser508 (AC V numbering) [12] (Fig. 2B). Differences between
Kd values of FS equilibrium dialysis binding and EC50 values of FS for activation of catalysis
by C1/C2 raised the question of two FS binding sites [10]. In accordance with this assumption,
in the C2/C2 homodimer crystal, two FS molecules are found [16]. However, in the C1/C2
heterodimer crystal, there is only one FS binding site [12]. Moreover, dissociations between
binding affinity and potency for activation of catalysis were observed for intact ACs [17,18].
Accordingly, the aim of the present study was to improve our knowledge on the mechanism
of AC activation by FS. In order to achieve our aim, we systematically examined the effects
of FS and eight FS analogs (Fig. 1) on FRET to, and direct fluorescence of, MANT-GTP, as
well as catalysis of C1/C2.
2. Materials and Methods
2.1. Materials
FS was purchased from LC Laboratories (Woburn, MA, USA). DMB-FS was from Calbiochem
(La Jolla, CA, USA). All other FS analogs were from Sigma-Aldrich (St. Louis, MO, USA).
Stock solutions of FS and FS analogs (10 mM each) were prepared in DMSO. Dilutions of FS
analogs were prepared in such a way that in all fluorescence and enzymatic activity assays a
final DMSO concentration of 3% (vol/vol) was achieved. MANT-GTP was obtained from Jena
Bioscience (Jena, Germany). VC1 and IIC2 and GTPγS-activated Gsα (Gsα-GTPγS) were
expressed and purified as described [11]. [α-32P]ATP (800 Ci/mmol) was purchased from
PerkinElmer (Wellesley, MA, USA). Neutral alumina (super I, WN-6) was from Sigma.
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All experiments were conducted using a Cary Eclipse fluorescence spectrophotometer
equipped with a Peltier-thermostated multicell holder at 25°C (Varian, Walnut Creek, CA,
USA). Measurements were performed in a quartz fluorescence microcuvette (Hellma,
Plainview, NY, USA). The final assay volume was 150 μl. Reaction mixtures contained a buffer
consisting of 100 mM KCl, 10 mM MnCl2 and 25 mM HEPES/NaOH, pH 7.4, and 1 μM
MANT-GTP. Steady-state emission spectra were recorded at low speed with λex = 350 nm
(λem = 370–500 nm) (direct fluorescence) and λex = 280 nm (λem = 300–500 nm) (FRET) in
the presence of 5 μM VC1 plus 25 μM IIC2 without and with FS or FS analogs at various
concentrations. The final DMSO concentration was 3% (vol/vol). DMSO at this concentration
had no effect on MANT-GTP fluorescence (data not shown). Fluorescence recordings were
analyzed with the spectrum package of the Cary Eclipse software (Varian, Walnut Creek, CA).
In all experiments, baseline fluorescence (buffer alone) was subtracted.
2. 3. AC activity assay
AC activity was determined essentially as described in the literature [13]. Briefly, reaction
mixtures (50 μl final volume) contained 100 μM ATP/Mn2+ and 10 mM MnCl2 or 100 μM
ATP/Mg2+ and 10 mM MgCl2 and FS or FS analogs at various concentration in the presence
of 3% (vol/vol) DMSO. Additionally, assay tubes contained VC1 (8 nM) and IIC2 (40 nM).
For experiments with Gsα-GTPγS, tubes contained VCI (3 nM), IIC2 (15 nM) and Gsα-GTPγS
(50 nM). Following a 2 min pre-incubation at 30°C, reactions were initiated by adding 20 μl
of reaction mixture containing (final) 1.0–1.5 μCi/tube [α-32P]ATP, 0.1 mM cAMP and 100
mM KCl in 25 mM HEPES/NaOH, pH 7.4, and a regenerating system consisting of 2.7 mM
mono(cyclohexyl)ammonium phosphoenolpyruvate, 0.125 IU pyruvate kinase and 1 IU
myokinase. Reactions were conducted for 20 min at 30°C and were terminated by adding 20
μL of 2.2 N HCl. Denatured protein was precipitated by a 1 min centrifugation at 25°C and
15,000 × g. Sixty-five μl of the supernatant fluid were applied onto disposable columns filled
with 1.3 g neutral alumina. [32P]cAMP was separated from [α-32P]ATP by elution of [32P]
cAMP with 4 ml of 0.1 M ammonium acetate, pH 7.0. Recovery of [32P]cAMP was ~80% as
assessed with [3H]cAMP as standard. [32P]cAMP was determined liquid scintillation counting
using Ecolume scintillation cocktail (Fisher, Pittsburgh, PA, USA). Data were analyzed by
non-linear regression using the Prism 4.02 program (GraphPad, San Diego, CA, USA).
2.4. Statistics
Statistical comparisons in Figs. 5 and 6 and Table 1 were performed using the t-test. Differences
were considered as statistically significant with *p < 0.05 and ** p < 0.01.
3. Results
3.1. Effects of FS and FS analogs on fluorescence properties of MANT-GTP bound to C1/C2
MANT-GTP is directly excited at λex = 350 nm [13,14], resulting in emission with a maximum
at λem = 450 nm (Fig. 3). Translocation of the MANT-group into a hydrophobic environment
increases fluorescence and results into a shift of the emission maximum to shorter wavelengths.
This phenomenon is also referred to as blue-shift. The addition of C1/C2 to cuvettes resulted
in a moderate increase in direct fluorescence and a decrease of the emission maximum to
λem = 430 nm. These data show that MANT-GTP binds to C1/C2 already in the absence of an
activator, with the MANT-group residing in a hydrophobic pocket at the interface between the
C1- and C2 subunit [13,14]. FS enhanced this fluorescence increase and reduced the emission
maximum to λem = 425 nm. The effect of FS was concentration-dependent and reached a
maximum at 30 μM. These data show that FS enhances C1/C2 assembly and/or facilitates
formation of the hydrophobic pocket.
Pinto et al. Page 3













We also examined FRET from tryptophan and tyrosine residues in C1/C2 to the MANT-group.
At a wavelength of λex = 280 nm, MANT-GTP is only minimally excited, accordingly resulting
in minimal emission at λem = 450 nm. In marked contrast, the trypophan residues, particularly
Trp1020 of IIC2, and tyrosine residues of C1 and C2 are effectively excited at λex = 280 nm,
resulting in a large fluorescence emission with a maximum at λem = 350 nm. Thus, the
fluorescence light emitted at λem 350 nm can excite the MANT-group of MANT-GTP,
provided sufficiently close proximity of donor and acceptor. In fact, the distance between
Trp1020 of IIC2 and the MANT-group is less than 5 Å, allowing for FRET to occur [13,14].
Basal FRET between Trp1020 and MANT-GTP, i.e. FRET in the absence of FS, is
characterized by the emission shoulder between λem 420–450 nm. The addition of FS at
increasing concentrations decreased the endogenous C1/C2 fluorescence at λem = 350 nm,
reflecting absorption of energy by the MANT-group of MANT-GTP. The absorbed energy
then excited the MANT-group and resulted in concomitant increases in fluorescence with a
maximum at λem = 420–425 nm, again reflecting C1/C2 assembly or more efficient formation
of the hydrophobic pocket. Like in the direct fluorescence experiments, the effect of FS on
FRET reached a maximum at a concentration of 30 μM. Thus, both the direct fluorescence
assay and the FRET assay allowed us to monitor binding of FS analogs to C1/C2.
Fig. 4 shows representative original tracings for the stimulatory effects of FS and FS analogs
(100 μM each) on FRET and direct MANT-GTP fluorescence with C1/C2, and Fig. 5 provides
a statistical summary of the effects of the diterpenes on FRET and direct fluorescence.
Diterpenes stimulated FRET and direct MANT-GTP fluorescence in the order of efficacy FS
~ 7DA-FS ~ 6A7DA-FS ~ 9d-FS > DMB-FS > 1d-FS ~ 1,9-dd-FS ~ 7DA1d-FS ~ 7DA1,9dd-
FS.
In order to assess the specificity of the effects of diterpenes on direct MANT-GTP fluorescence
and FRET, we performed a number of control experiments. First, none of the diterpenes studied
exhibited a fluorescence signal when excited at λex = 280 nm and λex = 350 nm in buffer in
the absence and presence of MANT-GTP. Second, in the presence of MANT-GTP and C2 but
in the absence of C1, diterpenes did not elicit an increase in direct MANT-GTP fluorescence
or FRET. Third, in the presence of MANT-GTP and C1 but in the absence of C2, diterpenes
failed to increase direct MANT-GTP fluorescence and FRET as well (data not shown). These
data indicate that for the fluorescence signals reported in Figs. 3–5, both the C1- and the C2
subunit are required, ruling out non-specific diterpene effects.
3.2. Effects of FS and FS analogs on the catalytic activity of C1/C2
Fig. 6A shows representative concentration/response curves for the stimulatory effects of FS
and FS analogs on the catalytic activity of C1/C2 in the presence of Mn2+ and Gsα, and Table
1 provides a statistical summary of the effects of diterpenes on catalysis. FS analogs activated
catalysis in the order of potency 6A7DA-FS ~ 7DA-FS > FS > 9d-FS > DMB-FS. The order
of efficacy was FS > 7DA-FS ~ 6A7DA-FS ~ 9d-FS > DMB-FS ≫ 1d-FS, 1,9dd-FS, 7DA1-
FS and 7DA1,9dd-FS (ineffective).
We also examined the effects of some of the ineffective 1d-FS analogs at a fixed concentration
on the concentration/response for FS. 1d-FS, 1,9dd-FS and 7DA1d-FS decreased the efficacy
of FS by ~50% without decreasing the potency of FS, i.e. the FS analogs inhibited the effects
of FS non-competitively.
Finally, the effects of FS and FS analogs were examined on catalysis by C1/C2 in the presence
of Mn2+ and in the absence of Gs, and by C1/C2 in the presence of Gs and Mg2+ (Table 1).
Under those conditions, it was impossible to obtain saturated concentration/response curves
for the diterpenes so that we could only determine efficacies of compounds at a single high
concentration (100 μM). Except for DMB-FS and 7DA-FS under Mg2+ conditions with Gs,
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efficacies of all diterpenes relative to FS substantially decreased compared to Mn2+ conditions
with Gs. Again, all 1d-FS analogs did not activate catalysis by C1/C2.
4. Discussion
4. 1. Two-step mechanism of AC activation by diterpenes
The most important finding of this study is that all FS analogs, regardless of their substitution
at C1, C6, C7 and C9 of the diterpene ring (Fig. 1), promote C1/C2 assembly as assessed by
fluorescence spectroscopy (Figs. 3–5). Thus, we conclude that for diterpene binding to AC,
hydrophobic interactions are critical. Given the large C1/C2 hydrophobic interface [12] (Fig.
2A), at first glance, this finding may not appear surprising. However, from previous [3H]FS
binding studies and enzyme activity measurements with intact ACs it was concluded that the
lack of the C1-OH group results in inactive FS analogs that do not bind to AC anymore [4,5].
A major difference between our present study and the previous studies is that we examined
purified AC subunits, whereas in previous studies, membranes expressing AC and multiple
other proteins were used. Given the fact that AC is not the only protein that binds FS [5], the
most likely explanation for the discrepancies is that previous [3H]FS binding studies did not
monitor AC but rather proteins such as ion channels or glucose transporters. This conclusion
is supported by the fact that previous binding studies with membranes reported on a high-
affinity [3H]FS site (Kd in the 10 nM-range) [4,5], whereas equilibrium dialysis binding studies
and catalysis studies with purified C1/C2 show that the affinity of AC for FS is about three
orders of magnitudes higher, i.e. in the 10 μM-range (Fig. 6 and Table 1) [10].
The second most important finding of our study is that deletion of the C1-OH group, regardless
of the substitution of C7, C6 and C9, results in a complete loss of stimulatory effect of diterpenes
on catalysis (Fig. 6 and Table 1). These findings support the previous suggestion that diterpene
binding to AC is not sufficient for activation of catalysis [2,12]. Rather, we propose that a
conformational switch in AC, triggered by hydrogen bonding of the diterpene C1-OH group
to the backbone oxygen of Val506 (AC V) [12] is essential for stimulating catalysis. Thus, AC
activation occurs through a two-step mechanism. In the first step, diterpene binding to the
hydrophobic site occurs, and in the second step, hydrogen bonding between C1-OH and Val506
triggers a crucial conformational change activating catalysis.
We would like to emphasize that presently, we do have direct evidence for the proposed
activating conformational change in AC. In an effort to answer this crucial question, we have
actually already undertaken substantial efforts to crystallize C1/C2 in complex with
Gsα-GTPγS, MANT-GTP and 1d-FS or 1,9dd-FS, but so far, these efforts have not yet been
successful for unknown reasons. However, the fact that 1d-FS derivatives reduce basal catalysis
of holo-AC2 expressed in Sf9 cell membranes [9] supports the view that 1d-FS derivatives do
bind to AC but do not trigger the supposed activating conformational change. In case of AC2,
1d-FS analogs may rather stabilize an inactive enzyme conformation (see also Discussion
below). In view of the difficulties with crystallography, future molecular modelling studies,
which are beyond the scope of the present study, may be helpful to elucidate the conformational
change in AC.
4.2. Molecular analysis of the interaction of FS analogs with C1/C2
In previous studies it was often difficult to obtain saturated concentration/response curves for
diterpenes, rendering calculation of potencies and efficacies arbitrary [4,5,8]. In the initial
phase of this project, we also experienced substantial difficulties in obtaining saturated
concentration/response curves for diterpenes since we limited the final DMSO concentration
in assays to 1% (vol/vol). However, when increasing the DMSO concentration to 3% (vol/vol),
saturated concentration/response curves could be achieved without compromising
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fluorescence signals and catalytic activity. Unfortunately, previous studies often only
incompletely defined solvent conditions. None of the FS analogs studied herein surpassed FS
in terms of efficacy for catalysis. Rather, depending on the specific experimental conditions
chosen, FS analogs exhibited slightly to strongly reduced efficacies (Fig. 6 and Table 1). Thus,
AC could be considered as a “FS receptor” with ligands exhibiting efficacies ranging from full
agonism via partial agonism to antagonism. By analogy to the two-state model of receptor
activation [19], one could have expected that non-stimulatory FS analogs actually decrease
basal AC activity as inverse agonists, but no such inhibition was observed (Fig. 6 and Table
1). This is probably due to the low catalysis rate under those conditions. In contrast, holo-AC2
exhibits high basal catalytic activity, and under those conditions, non-stimulatory FS analogs
actually decrease basal activity [9].
In contrast to the C1-OH group, the C9-OH group does not form a hydrogen bond with C1/C2
[12] (Fig. 2). Accordingly, it was not surprising to observe that deletion of the C9-OH group
had only minor effects on the efficacy of 9d-FS to bind to, and activate catalysis of, C1/C2
(Figs. 4–6 and Table 1).
In addition to the hydrogen bond between the diterpene C1-OH group and Val506 of C1 (AC
V), there is a hydrogen bond between the acetyl group of C7 and Ser942 of C2 (AC II) mediated
via a water molecule [12] (Fig. 2). However, the latter hydrogen bond plays only a relatively
small role in diterpene binding to, and activation of catalysis by, C1/C2, since potencies and
efficacies of 7DA-FS in terms of fluorescence signals and catalysis were similar to those of
FS (Figs. 4–6). In accordance with those findings is the fact that the exchange of the acetyl
group from C7 to C6 is well tolerated in terms of binding and catalysis. However, in conjunction
with a missing C1-OH group, deletion of the C7-acetyl group reduced diterpene efficacy at
promoting C1/C2 assembly (Figs. 4 and 5), indicating that the hydrogen bonds stabilize
diterpene/AC interactions under certain conditions.
FS and DMB-FS bind to AC very similarly, i.e. the root mean square deviation (RMSD) of
FS/DMB-FS and the surrounding amino acids of C1/C2 was less than 1.1 Å (Fig. 2). Thus, we
were surprised that the N-methylpiperazino-γ-butyryloxy substituent of DMB-FS was not well
tolerated in terms of potency and efficacy for activation of catalysis although the substituent
does not sterically interfere with ligand binding to AC (Figs. 2 and 6 and Table 1). We also
noted significantly reduced efficacy of DMB-FS relative to FS with respect to C1/C2 assembly
(Figs. 4 and 5). These data suggest that the minor differences in positioning of DMB-FS and
FS in the binding pocket (Figs. 2, 4 and 5) are actually amplified in rather large differences
with respect to catalysis (Fig. 6 and Table 1).
Under optimal conditions for catalysis, i.e. in the presence of Mn2+ and Gs [11,13], the C7-
acetyl group, the switch from C7-acetyl to C6-acetyl and the omission of the C9-OH group had
only small effects on efficacy. In contrast, the exchange of Mn2+ against Mg2+ and the omission
of Gs substantially reduced diterpene efficacies (and potencies) (Table 1), indicating that
stabilizing interactions in AC provided by Mn2+and Gs can compensate for missing interactions
of AC with FS analogs. Comparing the efficacies of diterpenes (100 μM each) at promoting
C1/C2 assembly in the presence of Mn2+ and in the absence of Gs with the corresponding
efficacies in terms of catalysis, the discrepancies between the two parameters become even
more striking (Fig. 5 and Table 1). For example, 7DA-FS (100 μM) was as effective as FS at
promoting C1/C2 assembly but exhibited just 20% of the efficacy of FS at stimulating catalysis.
These dissociations further corroborate the concept that following diterpene binding to AC
driven by hydrophobic interactions, an additional conformational switch is required to activate
catalysis. The most important conformational change is afforded by the diterpene C1-OH-
Val506 interaction (Fig. 2), but in the absence of Gs, interactions of the C7-acetyl group with
Ser942 via a water molecule play a role in the activation process as well. Thus, activation of
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catalysis by diterpenes is regulated by multiple conformational switches which depend on the
presence of other modulators such as Mg2+, Mn2+ and Gs.
4.3. 1d-FS derivatives as FS antagonists
If 1d-FS derivatives were FS antagonists in the sense of receptor theory [20], they should not
only fail to activate catalysis, but they should also competitively inhibit the stimulatory effects
of FS. In fact, all 1d-FS derivatives examined inhibited FS-stimulated catalysis (Fig. 6 and
Table 1). However, the inhibitory effects of diterpenes on FS-stimulated catalysis were non-
competitive, raising the question whether FS and 1d-FS derivatives bind to different sites.
Based on the fluorescence studies, there is, however, no evidence for different binding sites
for diterpenes with and without C1-OH group since the fluorescence signals were qualitatively
comparable for the two classes of ligands (Fig. 4). In addition, based on the crystal structures
for C1/C2 [12–14], there is no evidence for a second diterpene binding site. Rather, it is
conceivable that strong hydrophobic interactions of diterpenes with C1/C2 impair the free
exchange of FS and 1d-FS analogs, resulting in apparently non-competitive ligand interactions
[9,21]. Difficulties in obtaining true equilibrium conditions are also the most likely explanation
for the inability to unequivocally identify a single FS binding site in C1/C2 by equilibrium
dialysis experiments [10].
4.4. Comparison of C1/C2 with holo-ACs
The C1/C2 system allows for the analysis of diterpene/AC interactions by fluorescence
spectroscopy, whereas such analysis is impossible with holo-ACs expressed in Sf9 cell
membranes. This difference is mainly due to the fact that for fluorescence spectroscopy, very
high protein concentrations, i.e. concentrations in the μM-range, are required that cannot be
achieved in a membrane overexpression system. However, the C1/C2 system is artifical in the
sense that it consists only of small fragments in relation to the intact AC protein, rendering the
model much more sensitive to entropy-related effects than holo-ACs which are more rigid
proteins [1–3]. Therefore, it is important to directly compare the pharmacological effects of
diterpenes at C1/C2 and holo-ACs. Indeed, in terms of potency and efficacy, there are
quantitative differences in the effects of FS, DMB-FS, 7DA-FS, 6A7DA-FS and 9d-FS at C1/
C2 compared to holo-ACs (Table 1) [9]. However, one cannot readily attribute those
differences to entropic differences between the two systems since C1/C2 is actually a hybrid
with components from two AC isoforms (C1 from AC5 and C2 from AC2). To render issues
even more complex, holo-AC2 and holo-AC5 differ from each other quite considerably with
respect to the pharmacological profile of diterpenes and the inhibition pattern by MANT-
nucleotides [9,22]. Thus, future studies will have to compare a given holo-AC with the
corresponding C1- and C2 subunits from the same AC isoform. We have already tried to
express C2 from AC5 and C1 from AC2, but to this end, we have not yet obtained functionally
active protein.
Despite these problems in the precise comparison of C1/C2 with holo-ACs, there are some
findings that lend support to the notion that data obtained with C1/C2 are relevant for holo-
ACs. Specifically, 1d-FS derivatives uniformly failed to activate C1/C2 and all recombinant
holo-ACs studied, including ACs 2 and 5 (Fig. 6 and Table 1) [9]. Furthermore, in native mouse
heart membranes, 1d-FS does not increase AC activity [23]. Moreover, 1d-FS derivatives
showed apparent non-competitive interaction with FS in all systems studied so far (Fig. 6)
[9]. These data indicate that the two-step mechanism of AC activation proposed for C1/C2 can
also be applied to holo-ACs. This concept is further corroborated by the inhibitory effect of
1d-FS derivatives on the high basal activity of AC2 [9].
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Binding of diterpenes to the purified catalytic subunits of AC occurs mainly via hydrophobic
interactions. However, activation of catalysis requires an additional conformational switch
triggered by a hydrogen bond between the C1-OH group of diterpenes and the backbone oxygen
of Val506 of C1. Additional hydrogen-bonding substituents of diterpenes modulate activation
of catalysis. 1d-FS analogs inhibit FS-stimulated catalysis by an apparently non-competitive
interaction, which is presumably due to strong hydrophobic diterpene/AC interactions,
impairing free ligand exchange. Future studies will have to elucidate the precise nature of the
proposed second conformational switch. With repect to potential therapeutic applications, it
will also be important to examine the effects of diterpenes in native systems such as organ
membranes and intact organs. In fact, a recent study on mouse heart AC showed that in this
system, multiple AC isoforms contribute to the overall effects of diterpenes, rendering the
pharmacological profile very complex [23].
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Fig. 1. Structures of FS and FS analogs
A , FS; B, 1,9dd-FS; C, 1d-FS; D, 9-d-FS; E, 7DA-FS; F, 6A7DA-FS; G, 7DA1,9dd-FS; H,
7DA1d-FS; I, DMB-FS.
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Fig. 2. FS binding site in mammalian AC
The AC structure with DMB-FS (PDB: 1AZS) is superimposed on both C1 and C2 domains
of the AC structure with FS (PDB:1CS4). A, overview. The molecular surface of the VC1 and
IIC2 proteins in the diterpene binding pocket is displayed in light-blue and light-pink,
respectively. FS and DMB-FS are drawn as stick models; carbon atoms are gray for FS and
yellow for DMB-FS, nitrogens blue, and oxygens red. Three conserved residues from VC1
forming a binding pocket in proximity to the C1-OH group of FS/DMB-FS are colored
magenta for Asp505, green for Val506, and orange for Trp507. A water molecule bridges the
side chain of Ser942 (cyan) from IIC2 and two oxygens of the FS/DMB-FS. B, detail view.
VC1 and IIC2 are shown in lime and pink, respectively. Secondary structure elements are
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labeled as defined previously [12]. FS and DMB-FS are drawn as stick models; carbon atoms
are cyan for FS, yellow for DMB-FS and gray for side chains of protein residues, nitrogens
blue, and oxygens red. The white dashed lines depict the hydrogen bonds between amino acid
residues Val506 of VC1 and C1-OH of FS, Ser942 (IIC2) and C7-OH of FS via a water molecule
as well as Ser508 (VC1) and C11-OH of FS. Fig. 2 was generated using the PyMol program
(DeLano Scientific, San Carlos, CA, USA).
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Fig. 3. Cumulative concentration/response curves for the effects of FS on FRET and direct MANT-
GTP fluorescence in C1/C2
Fluorescence studies were performed as described in “Materials and Methods”. Fluorescence
spectra are shown at λex= 280 nm (λem = 300–500 nm, left-hand graph) (FRET) and at λex =
350 nm (λem = 370–500 nm) (direct fluorescence, right-hand graph). Fluorescence
measurements were performed in a quartz florescence microcuvette at 25°C. Reaction mixtures
contained 100 mM KCl, 10 mM MnCl2 and 25 mM HEPES/NaOH, pH 7.4 and MANT-GTP
(1 μM). The final assay volume was 150 μl and the final DMSO concentration was 3% (vol/
vol). FS was added cumulatively to cuvettes to yield final concentrations of 1–151 μM. The
C1 and C2 concentrations were 5 and 25 μM, respectively. Tracings are defined as follows.
Blue, MANT-GTP; green, C1/C2; yellow, 1 μM FS; black, 11 μM FS; purple, 31 μM FS;
red, 151 μM FS. Fluorescence intensities are shown in arbitrary units (a. u.). Fluorescence
tracings are representative for three independent experiments.
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Fig. 4. Effects of FS and FS analogs on FRET and direct MANT-GTP fluorescence in C1/C2
Fluorescence studies were performed as described in “Materials and Methods”. Shown are the
effects of FS, DMB-FS, 9d-FS, 7DA-FS, 6A7DA-FS, 1,9dd-FS, 1d-FS, 7DA1,9dd-FS and
7DA1d-FS (Panels A–I, respectively) on MANT-GTP fluorescence. Fluorescence spectra are
shown at λex = 280 nm (λem = 300–500 nm) (FRET, left-hand graph) and at λex = 350 nm
(λem = 370–500 nm) (direct fluorescence, right-hand graph). Fluorescence measurements were
performed in a quartz fluorescence microcuvette at 25°C. Reaction mixtures contained 100
mM KCl, 10 mM MnCl2 and 25 mM HEPES/NaOH, pH 7.4, MANT-GTP (1 μM) and FS or
FS analogs (100 μM). The final assay volume was 150 μl and the final DMSO concentration
was 3% (vol/vol). The order of addition of the reagents was MANT-GTP (blue tracings),
followed by C1/C2 (green tracings), followed by FS or FS analogs (red tracings). Fluorescence
intensities are shown in arbitrary units (a. u.). Fluorescence tracings are representative for three
to five independent experiments with at least two different batches of protein.
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Fig. 5. Efficacies of FS and FS analogs at stimulating direct MANT-GTP fluorescence and at
inducing FRET in C1/C2
Fluorescence experiments were performed as illustrated in Fig. 4. Data were normalized
relative to the effect of FS (100 μM, = 100%). All FS analogs were used at a concentration of
100 μM. Panel A shows normalized direct fluorescence increase of MANT-GTP at λex = 350
nm and λem = 420 nm induced by FS and FS derivatives in the presence of 10 mM Mn2+. Direct
fluorescence was calculated subtracting basal fluorescence at λem = 420 nm (C1/C2 + MANT-
GTP) from the corresponding fluorescence determined in the presence of FS analogs. Panel
B shows normalized FRET from Trp1020 to MANT-GTP induced by FS and FS derivatives
at λex = 280 nm and λem = 420 nm in the presence of 10 mM Mn2+. FRET was calculated by
subtraction of the F420/F335 ratios of basal fluorescence from the corresponding ratio in the
presence of FS analogs. Data from three to five experiments with at least two independent
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batches of protein were pooled and are shown as means ± SD. Statistical comparisons between
FS and different analogs were performed using the t-test. * p < 0.05 and ** p < 0.01.
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Fig. 6. Effect of FS and FS analogs on the catalytic activity of C1/C2
Enzymatic studies were performed as described in “Materials and Methods”. Shown are
representative concentration/response curves for the stimulatory activities of FS analogs
relative to FS (panel A) and for the non-competitive antagonism of FS-stimulated C1/C2
catalysis by 7DA-1,9dd-FS, 1,9dd-FS or 1d-FS (panel B). Activities are expressed in % relative
to the maximum activity induced by FS (100 μM). Experiments were conducted in the presence
of Mn2+ (10 mM), C1 (3 nM), C2 (15 nM), Gsα-GTPγS (50 nM), ATP (100 μM), KCl (100
mM), [α-32P]ATP (1.0 – 1.5 μCi/tube), 3% (vol/vol) DMSO and increasing concentrations
(300 nM - 100 μM) of different diterpenes as indicated. Data were analyzed by non-linear
regression and best fitted to sigmoidal concentration/response curves. Data are the mean values
± SD of a representative experiment performed in duplicates. Similar results were obtained in
3–4 independent experiments. Basal catalytic activity of C1/C2 was 29 ± 0.5 nmol/mg C1/min,
and maximum FS-stimulated catalytic activity was 680 ± 32 nmol/mg C1/min.
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Table 1
Potencies and efficacies of FS and FS analogs for activation/inhibition of C1/C2 catalytic activity under different
experimental conditions
Diterpene
C1/C2 + Gsα +
Mg2+ C1/C2 + Mn2+ C1/C2 + Gsα + Mn
2+
Efficacy (%) Efficacy (%) Efficacy (%) EC50 (μM)
FS 100 100 100 7.4 ± 1.2
DMB-FS 33 ± 1 15 ± 4 41 ± 6** 27.6 ± 7.0 **
7DA-FS 83 ± 2 21 ± 6 86 ± 3 * 3.1 ± 1.4 **
6A7DA-FS 43 ± 2 36 ± 8 83 ± 14 2.6 ± 1.0 **
9d-FS 33 ± 17 29 ± 5 79 ± 13 19.5 ± 0.7 **
1d-FS ineffective ineffective ineffective ineffective
1,9dd-FS ineffective ineffective ineffective ineffective
7DA1,9dd-FS ineffective ineffective ineffective ineffective
7DA1d-FS ineffective ineffective ineffective ineffective
FS + 1d-FS N.D. N.D. 46 ± 1 ** 1.2 ± 0.7 *
FS + 1,9dd-FS N.D. N.D. 52 ± 2 ** 5.6 ± 1.7
FS + 7DA1,9dd-FS N.D. N.D. 47 ± 1 ** 2.9 ± 0.9 *
Catalytic activity of C1/C2 was determined as described under “Materials and Methods”. Experiments were conducted in the presence of Mg2+ or
Mn2+ (10 mM each), and in presence of C1 (3 nM), C2 (15 nM) plus Gsα-GTPγS (50 nM) or in the presence of C1 (8 nM) plus C2 (40 nM) without
Gsα. Assays contained ATP (100 μM), KCl (100 mM), ([α-32P] ATP (1.0–1.5 μCi/tube), 3% (vol/vol) DMSO and diterpenes at various concentrations.
The efficacy for each analog was determined by dividing the fitted maximal stimulation obtained for the analog by the maximum stimulation obtained by
treatment of C1/C2 with 100 μM FS. Basal catalytic activities with C1/C2 + Mg2+ + Gsα-GTPγS, C1/C2 + Mn2+ and C1/C2 + Mn2+ + Gsα-GTPγS
were 4.3 ± 0.7, 1.2 ± 0.9 and 27 ± 0.3 nmol/mg C1/min respectively. Maximum FS-stimulated catalytic activities were 57 ± 2, 167 ± 29 and 676 ± 36
nmol/mg C1/min, respectively. Data are the mean values ± SD of 3–4 independent experiments performed in duplicates. Statistical comparisons between
FS and different analogs were performed using the t-test.
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